Seer, Inc.

NASDAQ:SEER

Biotechnology

Healthcare
$1.39 +0.29%

+$0.01 today

Market cap
$77.30M
Beta
1.59
P/E (TTM)
-1.4
EPS (TTM)
-$1.26
52W Low $1.65High $2.41

Volume 0.25M

Average 0.32M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$44.45M

FY 2025 · Annual

Investing Cash Flow

$61.55M

FY 2025 · Annual

-6.5% YoY

Financing Cash Flow

-$10.57M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(71.17M)(92.97M)(86.28M)(86.6M)(73.6M)
Depreciation & Amortization2.56M3.94M5.58M6.18M7.25M
Deferred Income Tax1.2M0000
Stock-Based Compensation25.93M33.67M34.42M28.21M15.41M
Change in Working Capital(5.87M)(7.09M)(2.72M)(144K)(579K)
Accounts Receivables(2.5M)(2.87M)302K487K277K
Inventory(3.59M)(1.59M)(1.95M)(2.67M)(2.9M)
Accounts Payables1.6M(1.55M)(987K)3.36M1.06M
Other Working Capital(1.38M)(1.07M)(91K)(1.32M)983K
Other Non-Cash Items1.01M1.66M(10.07M)6.25M7.07M
Operating Cash Flow(46.35M)(60.78M)(59.07M)(46.11M)(44.45M)
Capital Expenditures(6.92M)(10.27M)(7.31M)(3.58M)(1.8M)
Acquisitions (Net)163.96M0000
Purchases of Investments(279.96M)(366.27M)(403.09M)(272.93M)(173.17M)
Sales of Investments116M253.65M448.31M342.03M237.81M
Other Investing Activities(163.96M)170K0343K(1.3M)
Investing Cash Flow(170.88M)(122.72M)37.9M65.86M61.55M
Debt Repayment00000
Common Stock Issued102.96M000458K
Common Stock Repurchased(35K)(20K)(13K)(11.82M)(10.2M)
Dividends Paid00000
Other Financing Activities13.71M3.91M465K321K(827K)
Financing Cash Flow116.63M3.89M452K(11.5M)(10.57M)
Effect of Forex Changes00000
Net Change in Cash(100.59M)(179.61M)(20.71M)8.25M6.53M
Free Cash Flow(53.27M)(71.05M)(66.37M)(49.69M)(46.25M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$73.6M
+ D&A$7.2M
+ Stock-Based Comp$15.4M
+ Deferred Tax$0
- Working Capital-$579.0K
+ Other Non-Cash$7.1M
= Operating Cash Flow-$44.4M
- Capex-$1.8M
= Free Cash Flow-$46.2M

Analysis

FY2025 free cash flow is -$46.2M. FCF conversion is 62.8% of net income. Operating cash flow was -$44.4M, with capex of -$1.8M. The largest bridge item is Stock-Based Comp at $15.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
SC 13DSC 13D filingNov 2, 2026
8-KCurrent reportOct 29, 2026

Does SEER generate free cash flow?

Seer, Inc. (SEER) generated -$46.24M of free cash flow in fiscal 2025.

How much operating cash flow does SEER produce?

Operating cash flow was -$44.45M, before capital expenditures of $1.80M.